The new maternal RSV vaccine serves as a major step toward preventing RSV in infants after birth. However, the vaccine’s rollout has come with challenges, including cost and access issues. Brenna Hughes, MD, MSc, FACOG, from Duke University, and Naima Joseph, MD, MPH, FACOG, from Boston Medical Center, join Labor of Love host Veronica Pimentel, MD, MS, FACOG, to discuss the latest recommendations for RSV maternal vaccination and share advice on how clinicians can counsel patients on making the best choice for themselves and their families.